CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 384 enrolled
Drug / intervention
Oral furosemide +1 moredrug
Likely dose
Oral furosemide 20 milligramfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03556761
NCT03556761Phase 2Completed

Furosemide for Accelerated Recovery of Blood Pressure Postpartum

University of Pennsylvania·interventional·Posted Jun 14, 2018·Updated Sep 10, 2020

In Brief

A Phase 2 clinical trial evaluating Oral furosemide and Placebo Oral Tablet for Hypertension, Pregnancy-Induced. Completed, enrolled 384 participants across 1 site.

Detailed Summary

A randomized, double-blind, placebo-controlled single center investigation of furosemide's effect on postpartum blood pressure control in pregnancies affected by hypertensive disorders of pregnancy

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedJun 14, 2018
Enrollment StartJun 20, 2018
Primary CompletionDec 4, 2019
Study CompletionFeb 5, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.0 years ago

Interventions

Oral furosemidedrug

Furosemide (Lasix), 20 milligram, PO, PO, daily

Placebo Oral Tabletdrug

Placebo, PO, daily